$GNTX
GENTEX CORP Stock $gntx

$gntx Overview Financials Valuation SEC Filings Company Website

2015 Q1 Form 10-Q Financial Statement

#000035581115000025 Filed on May 05, 2015

Income Statement

Concept	2015 Q1	2014 Q1
Revenue	$368.9M	$335.7M
YoY Change	9.89%	24.58%
Cost Of Revenue	$225.8M	$204.4M
YoY Change	10.47%	16.14%
Gross Profit	$143.1M	$131.3M
YoY Change	8.98%	40.48%
Gross Profit Margin	38.78%	39.11%
Selling, General & Admin	$13.80M	$13.63M
YoY Change	1.21%	24.76%
% of Gross Profit	9.64%	10.38%
Research & Development	$21.59M	$20.49M
YoY Change	5.36%	9.66%
% of Gross Profit	15.09%	15.61%
Depreciation & Amortization	$21.28M	$19.83M
YoY Change	7.33%	43.6%
% of Gross Profit	14.87%	15.1%
Operating Expenses	$35.38M	$34.12M
YoY Change	3.7%	15.24%
Operating Profit	$107.7M	$97.18M
YoY Change	10.84%	52.19%
Interest Expense	-$200.0K	-$600.0K
YoY Change	-66.67%	-220.0%
% of Operating Profit	-0.19%	-0.62%
Other Income/Expense, Net	$709.4K	$4.515M
YoY Change	-84.29%	137.57%
Pretax Income	$108.4M	$101.7M
YoY Change	6.61%	54.66%
Income Tax	$31.23M	$33.13M
% Of Pretax Income	28.81%	32.57%
Net Earnings	$77.18M	$68.57M
YoY Change	12.57%	50.92%
Net Earnings / Revenue	20.92%	20.42%
Basic Earnings Per Share	$0.26	$0.24
Diluted Earnings Per Share	$0.26	$0.24
COMMON SHARES
Basic Shares Outstanding	295.0M shares	289.8M shares
Diluted Shares Outstanding	298.6M shares	293.4M shares

Balance Sheet

Concept	2015 Q1	2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$549.9M	$374.7M
YoY Change	46.76%	-27.73%
Cash & Equivalents	$549.9M	$374.7M
Short-Term Investments
Other Short-Term Assets	$33.50M	$29.20M
YoY Change	14.73%	17.74%
Inventory	$145.6M	$128.3M
Prepaid Expenses
Receivables	$201.8M	$171.3M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$930.8M	$703.6M
YoY Change	32.29%	-11.53%
LONG-TERM ASSETS
Property, Plant & Equipment	$372.6M	$358.9M
YoY Change	3.82%	3.12%
Goodwill	$307.4M	$307.4M
YoY Change	0.0%
Intangibles	$342.1M	$361.4M
YoY Change	-5.34%	1163.11%
Long-Term Investments	$115.5M	$109.0M
YoY Change	5.96%	-31.1%
Other Assets	$788.1M	$802.5M
YoY Change	-1.8%	329.58%
Total Long-Term Assets	$1.161B	$1.161B
YoY Change	-0.07%	117.14%
TOTAL ASSETS
Total Short-Term Assets	$930.8M	$703.6M
Total Long-Term Assets	$1.161B	$1.161B
Total Assets	$2.091B	$1.865B
YoY Change	12.14%	40.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$73.28M	$64.40M
YoY Change	13.8%	95.14%
Accrued Expenses	$90.42M	$102.7M
YoY Change	-11.98%	34.01%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$163.7M	$167.1M
YoY Change	-2.05%	52.41%
LONG-TERM LIABILITIES
Long-Term Debt	$256.3M	$263.8M
YoY Change	-2.84%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$256.3M	$263.8M
YoY Change	-2.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$163.7M	$167.1M
Total Long-Term Liabilities	$256.3M	$263.8M
Total Liabilities	$478.0M	$480.1M
YoY Change	-0.45%	186.3%
SHAREHOLDERS EQUITY
Retained Earnings	$1.020B	$866.2M
YoY Change	17.71%	23.5%
Common Stock	$585.2M	$499.3M
YoY Change	17.2%	13.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.613B	$1.385B
YoY Change
Total Liabilities & Shareholders Equity	$2.091B	$1.865B
YoY Change	12.14%	40.22%

Cashflow Statement

Concept	2015 Q1	2014 Q1
OPERATING ACTIVITIES
Net Income	$77.18M	$68.57M
YoY Change	12.57%	50.92%
Depreciation, Depletion And Amortization	$21.28M	$19.83M
YoY Change	7.33%	43.6%
Cash From Operating Activities	$108.0M	$97.72M
YoY Change	10.47%	0.31%
INVESTING ACTIVITIES
Capital Expenditures	-$16.30M	-$16.70M
YoY Change	-2.4%	24.63%
Acquisitions
YoY Change
Other Investing Activities	$1.200M	-$600.0K
YoY Change	-300.0%	-96.92%
Cash From Investing Activities	-$15.13M	-$17.30M
YoY Change	-12.54%	-47.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$15.92M	-$6.228M
YoY Change	-355.6%	-5.53%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$40.34M	-$15.33M
YoY Change	163.21%	31.37%
NET CHANGE
Cash From Operating Activities	$108.0M	$97.72M
Cash From Investing Activities	-$15.13M	-$17.30M
Cash From Financing Activities	-$40.34M	-$15.33M
Net Change In Cash	$52.48M	$65.10M
YoY Change	-19.38%	23.12%
FREE CASH FLOW
Cash From Operating Activities	$108.0M	$97.72M
Capital Expenditures	-$16.30M	-$16.70M
Free Cash Flow	$124.3M	$114.4M
YoY Change	8.59%	3.25%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q1	dei	Amendment Flag AmendmentFlag	false
CY2015Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2015Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015Q1	dei	Document Period End Date DocumentPeriodEndDate	2015-03-31
CY2015Q1	dei	Document Type DocumentType	10-Q
CY2015Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000355811
CY2015Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	294192247	shares
CY2015Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2015Q1	dei	Entity Registrant Name EntityRegistrantName	GENTEX CORPORATION
CY2015Q1	dei	Trading Symbol TradingSymbol	gntx
CY2015Q1	gntx	Effectof One Percentage Point Increaseon Borrowing Rateto Interest Expense EffectofOnePercentagePointIncreaseonBorrowingRatetoInterestExpense	2700000	USD
CY2014Q4	gntx	Patentsand Other Assets Net PatentsandOtherAssetsNet	23627931	USD
CY2015Q1	gntx	Patentsand Other Assets Net PatentsandOtherAssetsNet	23139088	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	71456983	USD
CY2015Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	73284660	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	168008704	USD
CY2015Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	201782059	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	61974180	USD
CY2015Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	90417747	USD
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	19483799	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	11313015	USD
CY2015Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	8803947	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	553836483	USD
CY2015Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	567470322	USD
CY2015Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4846051	USD
CY2014Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1188830	shares
CY2015Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1184635	shares
CY2014Q4	us-gaap	Assets Assets	2022540029	USD
CY2015Q1	us-gaap	Assets Assets	2091435105	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	856637694	USD
CY2015Q1	us-gaap	Assets Current AssetsCurrent	930766861	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	17855921	USD
CY2015Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	16934512	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1135425	USD
CY2015Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	791701	USD
CY2014Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	97923092	USD
CY2015Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	99354849	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1135425	USD
CY2015Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	791701	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	19972258	USD
CY2015Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	15894733	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	309591724	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	374688291	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	497429804	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	549911648	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	497429804	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	549911648	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	65096567	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	52481844	USD
CY2014Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.07
CY2015Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.08
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	17714877	USD
CY2015Q1	us-gaap	Common Stock Value CommonStockValue	17680567	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	66074507	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	74674373	USD
CY2014Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	204440537	USD
CY2015Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	225845046	USD
CY2014Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1614318	USD
CY2015Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-15354	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	59571421	USD
CY2015Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	58000242	USD
CY2014Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19825402	USD
CY2015Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	21279105	USD
CY2015Q1	us-gaap	Dividends Dividends	23600000	USD
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
CY2014Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.326
CY2015Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.288
CY2014Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	702580	USD
CY2015Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	1073744	USD
CY2014Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	702580	USD
CY2015Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	1073744	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	22000000	USD
CY2014Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-218409	USD
CY2015Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-221953	USD
CY2014Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-25808	USD
CY2015Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-300593	USD
CY2014Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	54520	USD
CY2015Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	44414	USD
CY2014Q1	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	5049229	USD
CY2015Q1	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	2912864	USD
CY2014Q4	us-gaap	Goodwill Goodwill	307365845	USD
CY2015Q1	us-gaap	Goodwill Goodwill	307365845	USD
CY2014Q1	us-gaap	Gross Profit GrossProfit	131298807	USD
CY2015Q1	us-gaap	Gross Profit GrossProfit	143092409	USD
CY2015Q1	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	101692090	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	108417890	USD
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33126019	USD
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31234449	USD
CY2015Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense Research And Development IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment	3900000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	7889358	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1827677	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	28290721	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	33773355	USD
CY2014Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	39907356	USD
CY2015Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	27731368	USD
CY2014Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8275303	USD
CY2015Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3806065	USD
CY2014Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	285354	USD
CY2015Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1150642	USD
CY2014Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-534133	USD
CY2015Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-15219554	USD
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	346875000	USD
CY2015Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	342050000	USD
CY2014Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	26841620	USD
CY2015Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	30080500	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	141757884	USD
CY2015Q1	us-gaap	Inventory Net InventoryNet	145563949	USD
CY2014Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	90780320	USD
CY2015Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	91275645	USD
CY2014Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	24135944	USD
CY2015Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	24207804	USD
CY2014Q1	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	325158	USD
CY2015Q1	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	612025	USD
CY2014Q4	us-gaap	Investments And Cash InvestmentsAndCash	612073392	USD
CY2015Q1	us-gaap	Investments And Cash InvestmentsAndCash	665409308	USD
CY2014Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	114643588	USD
CY2015Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	115497660	USD
CY2014Q4	us-gaap	Liabilities Liabilities	451127584	USD
CY2015Q1	us-gaap	Liabilities Liabilities	477952649	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2022540029	USD
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2091435105	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	133431163	USD
CY2015Q1	us-gaap	Liabilities Current LiabilitiesCurrent	163702407	USD
CY2014Q4	us-gaap	Long Term Debt LongTermDebt	258125000	USD
CY2015Q1	us-gaap	Long Term Debt LongTermDebt	256250000	USD
CY2014Q4	us-gaap	Long Term Investments LongTermInvestments	114642567	USD
CY2015Q1	us-gaap	Long Term Investments LongTermInvestments	115497100	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-15325712	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-40339061	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17299667	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15130941	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	97721946	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	107951846	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	68566071	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	77183441	USD
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4514544	USD
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	709384	USD
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	34121261	USD
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	35383903	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	97177546	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	107708506	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	792511343	USD
CY2015Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	788052033	USD
CY2014Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-91250	USD
CY2015Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-942974	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-3784041	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-3352349	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2491564	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2509068	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-1292477	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-843281	USD
CY2014Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	0	USD
CY2015Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	-1831690	USD
CY2014Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-3692791	USD
CY2015Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-577685	USD
CY2014Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4189386	USD
CY2015Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	97359	USD
CY2014Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2015Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	25049145	USD
CY2014Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	20380923	USD
CY2015Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	23619837	USD
CY2014Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	24487944	USD
CY2015Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	6360397	USD
CY2014Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	16417890	USD
CY2015Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	15160355	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	49441302	USD
CY2015Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	33509205	USD
CY2014Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6227631	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9131177	USD
CY2014Q1	us-gaap	Proceeds From Repayments Of Long Term Debt And Capital Securities ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities	-1875000	USD
CY2015Q1	us-gaap	Proceeds From Repayments Of Long Term Debt And Capital Securities ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities	-1875000	USD
CY2014Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	23856516	USD
CY2015Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	7540449	USD
CY2014Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	35005	USD
CY2015Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	4	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	373390992	USD
CY2015Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	372616211	USD
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20489227	USD
CY2015Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21587551	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	988548070	USD
CY2015Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1019527620	USD
CY2014Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	335739344	USD
CY2015Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	368937455	USD
CY2014Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13632034	USD
CY2015Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13796352	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4742080	USD
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5813951	USD
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0233
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0214
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.4036
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.3680
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0174
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0137
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.27
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.76
CY2015Q1	us-gaap	Share Based Goods And Nonemployee Services Transaction Capitalized Cost ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost	239947	USD
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y11M12D
CY2015Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y105D
CY2015Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	834750	shares
CY2015Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1406595	shares
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	1571412445	USD
CY2015Q1	us-gaap	Stockholders Equity StockholdersEquity	1613482456	USD
CY2014Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3600202	shares
CY2015Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3562712	shares
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	293437014	shares
CY2015Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	298594143	shares
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	289836812	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	295031431	shares

Files In Submission

Name	View Source	Status
0000355811-15-000025-index-headers.html	Edgar Link	pending
0000355811-15-000025-index.html	Edgar Link	pending
0000355811-15-000025.txt	Edgar Link	pending
0000355811-15-000025-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gntx-20150331.xml	Edgar Link	completed
gntx-20150331.xsd	Edgar Link	pending
gntx-20150331_cal.xml	Edgar Link	unprocessable
gntx-20150331_def.xml	Edgar Link	unprocessable
gntx-20150331_lab.xml	Edgar Link	unprocessable
gntx-20150331_pre.xml	Edgar Link	unprocessable
gntx03312015-10q.htm	Edgar Link	pending
gntx03312015-exx311.htm	Edgar Link	pending
gntx03312015-exx312.htm	Edgar Link	pending
gntx03312015-exx32.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GNTX
GENTEX CORP Stock $gntx

2015 Q1 Form 10-Q Financial Statement

#000035581115000025 Filed on May 05, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GNTX GENTEX CORP Stock $gntx

2015 Q1 Form 10-Q Financial Statement

#000035581115000025 Filed on May 05, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GNTX
GENTEX CORP Stock $gntx